Vapourtec Chips in with Reactor Housing
News Sep 29, 2015
Vapourtec (Cambridge, UK) has launched a reactor housing for micromixer reactors that complements its existing standard, cooled, heated and photochemical family of reactors.
Vapourtec's new micromixer, which plugs easily into ports within their current flow chemistry systems, features chip reactors housed within a glass and PTFE manifold that offers a clear visibility of the reactants.
Cooled gas is circulated around the micromixer chips, using Vapourtec's cooling module, to deliver temperatures as low as -40º C. Heated air, reaching temperatures up to 150º C, can also be circulated around the reactor.
Two chip reactors can be inserted into the micromixer reactor housing allowing one chip to be used for mixing and the other as a residence time chip by way of an example. In addition, multiple reactor housings can be used on either the Vapourtec R-Series or E-Series systems allowing up to 8 chips to be heated or cooled simultaneously facilitating the telescoping of flow reactions.
Vapourtec MD and founder Duncan Guthrie explained: "This is the latest addition to our range of continuous process reactors and it offers scope for chemists to explore smaller scale reactions."
The seven different chip reactors available cover volumes from 0.2ml to 1.7ml and provide options for one, two or three reagent inputs.
Vapourtec design and manufacture flow chemistry systems for a wide variety of sectors including education, pharmaceutical and industry with their technologies used by all of the major pharmaceutical brands.
Lab Innovations 2018 – Registration Opens and Keynotes AnnouncedNews
Learn and earn CPD points at the UK’s only lab-dedicated showcase and scientific seminar series.READ MORE
Synthesis Strategy Could Mean Wave of New Medicinal CompoundsNews
In pharmacology, not all molecular structures are created equal. Some frameworks are overrepresented in nature, making them especially attractive to scientists on the hunt for more effective drugs. One such structure, the carbocyclic 5-8-5 fused ring system, is notoriously difficult to produce using conventional laboratory methods. Now, an innovative synthetic technique could unlock these elusive structures.READ MORE
BioAscent Secures Investment to Expand its Integrated Drug Discovery ServicesNews
£1.6m investment recognises BioAscent’s unique capabilities.READ MORE